Sage Journals: Discover world-class research

Abstract

The synthesis of A-azepanobetulinic acid N-methylpiperazinylamide was performed through a series of transformations (oximation, Beckmann rearrangement, reduction) of previously synthesized betulonic acid N-methylpiperazinylamide. In vitro cytotoxic activity was detected for the obtained compound against a number of cancer cell lines, and its potential was revealed as an antibacterial agent.

Keywords

lupane triterpenoids А-azepanobetulinic acid piperazinylamide Beckmann rearrangement cytotoxicity antibacterial activity

Pentacyclic triterpenoids are a class of natural compounds widely represented in plant sources. The best-known representatives are betulinic, oleanolic, ursolic, and glycyrrhetinic acids. As evident from literature data, triterpenoids are characteristic of a diverse biological activity, especially antitumor and antimicrobial. For example, betulinic acid is in stage II clinical trials as an antitumor agent against melanoma.¹ Oleanolic acid shows high activity against hepatocellular carcinoma.² Besides, oleanolic and ursolic acids are well-known agents against Mycobacterium tuberculosis.³

Most terpene structures are characterized by common drawbacks, including low solubility, poor bioavailability, and instability to metabolism.⁴ In addition, they have a weak pharmacological effect at low concentrations.⁵ As a result, investigations into the chemical modification of the initial carbocyclic backbone have been undertaken in order to find biologically active compounds with an improved pharmacological profile and advanced mechanism of action against tumor cells. Various methods of triterpenoid molecule delivery to biological targets are being actively studied.⁶

One of the important pharmacophore groups in the triterpenoid modifications is the piperazinyl fragment responsible for various biological activities: antibacterial,⁷ anticancer,^8,9 antiviral,^10,11 antimalarial,¹² α-glucosidase inhibitory,¹³ antileishmanial,¹⁴ antifungal,¹⁵ etc.

This paper reports on the synthesis and study of the cytotoxicity and antibacterial activity of a new triterpene conjugate with N-methylpiperazine. Based on previously obtained data, concerning the antitumor and antituberculosis activity of azepanotriterpene alcohols and their derivatives,^16,17 we carried out the transformation of the carbocyclic ring A of betulonic acid N-methylpiperazinylamide 1 to a 7-member A-aza-ring (Scheme 1). At the first stage, compound 1 was transformed to oxime 2, and then converted to lactame 3 via the Beckmann rearrangement. The opening of lactame ring and formation of A-seco-nitrile as a byproduct (the structure is not shown) was also observed in minor amount under TLC monitoring and separated through crystallization of the target lactame. The reduction of compound 3 by LiAlH₄ in THF resulted in A-azepanobetulinic acid N-methylpiperazinylamide 4. The structure of compounds 2 -4 were determined by nuclear magnetic resonance (NMR) spectroscopy. The spectra of all compounds contained signals of amide bond (δ 173.4-174.1 ppm of ¹³C NMR) and N-methylpiperazinyl fragment (δ 2.06-2.45, 2.29, 2.32, 2.51-3.20 ppm of ¹H NMR).

Scheme 1

Synthesis of betulonic acid N-methylpiperazinylamide derivatives 1-5. Reagents and conditions: I. NH₂OH·HCl, EtOH, NaOAc, reflux, 2 hours; II. SOCl₂, dioxane, 0.5 hours, rt; III. LiAlH₄, THF, reflux, 1 hour; IV. NaBH₄, i-PrOH, rt, 2 hours.

In addition, the NMR spectra definitely showed the modification of ring A. For example, the signal of C3 in the spectra of lactame 3 was observed at δ 176.7 ppm, while the conversion to azepane ring led to strong field signal shift to δ 62.3 ppm.

Compounds 1 -5 were tested for antibacterial properties by measuring MIC (minimum inhibitory concentration) of the compound for BW25113 Escherichia coli and BW25113 E. coli ΔtolC (JW5503 from Keio collection). This strain lacks tolC gene and has problems with the efflux system, and it is more sensitive to different antibiotics.¹⁸ BW25113 E. coli was completely resistant to compound 4, meanwhile ΔtolC strain was sensitive and MIC was 12.5 ± 2.5 µg/mL. MIC for well-known antibiotic erythromycin was 2.5 ± 0.5 µg/mL (Table 1). Compounds 1 -3 and 5 were inactive under the indicated screening conditions. Hence, the presence of the 7-member A-aza-ring is critical for the antibacterial effect against E. coli strains in this case. An interesting fact was the difference in activity between compounds 3 and 4. Moderate values of the antibacterial effect of compound 4 give basis for its further chemical modification.

Table 1

Antibacterial Test Results for Compounds 1-5, MIC µg/mL.

Compds	BW25113 E. coli	S_d	BW25113 E. coli ΔtolC	S_d
1	>100	-	>100	-
2	>100	-	>100	-
3	>100	-	>100	-
4	>100	-	12.5	2.5
5	>100	-	>100	-
Erythromycin	50	2	2.5	0.5

Next, pDualrep2 system was used to analyze the mechanism of action of 4,¹⁹ but as distinct from erythromycin, or levofloxacin, compound 4 did not induce any reporter gene (data not shown). Thus, it is possible to suggest that it does not inhibit translation or DNA synthesis.

At the second stage, compound 4 was examined in cytotoxicity assay in vitro. The activity determination (CC₅₀ values) was performed using the MTT test. Paclitaxel was used as a reference drug. Compound 4 was tested against LNCaP, PC3, 22RW1, Huh7, and VA13 cell lines and showed a high level of activity in the range 0.2-1 µM (Table 2).

Table 2

Cytotoxicity Test Results for Compounds 1-5, СC₅₀ µM.

Compds	LNCAP	PC3	22RW1	Huh7	VA13
4	1.12	1.11	0.37	0.74	0.19
5	N/a	3.58	N/a	2.75	N/a^*
Paclitaxel	0.01	0.015	0.016	0.002	0.001

^* N/a, testing was not performed.

We speculate that key factor in this case is the presence of the N-methylpiperazinylamide fragment in the structure of 4. As a result, the compound obtained is an attractive example for the advanced researches, which is the goal of our ongoing research.

Moreover, we evaluated the activity of compound 5 against cell lines of hepatocarcinoma Huh7 and prostate cancer PC3. Due to the presence of 3-OH group this derivative can be esterified and used for target delivery to cancer cells via prodrug-type conjugates.^20,21 N-methylpiperazinylamide 5 also demonstrated high values of cytotoxicity, although appeared slightly less active in compare with 4.

Finally, the synthesis of A-azepanobetulinic acid N-methylpiperazinylamide was performed through a series of betulonic acid N-methylpiperazinylamide transformations (oximation, Beckmann rearrangement, reduction). As a result, obtained compound demonstrated its high-value activity against various tumor cell lines, as well as antibacterial potential. High antitumor effect of N-methylpiperazinylamide derivative of betulinic acid suggests the possibility of its use as a precursor for a variety of prodrug-like conjugates.

Experimental

General

NMR spectra were recorded at the Center for Collective Use “Chemistry” of the UIC UFRS RAS. NMR spectra were recorded on a “Bruker AM-300” spectrometer at 300 (¹H) and 75.5 MHz (¹³C) at 25°C. Chemical shifts were given in (δ in ppm) relative to the residual signals of CDCl₃ (¹H 7.24 ppm and ¹³C 76.90 ppm). Melting points were determined with a Boetius heating stage. Optical rotations were measured on Perkin-Elmer 241 polarimeter at room temperature (20°C to 22°C). Combustion analysis was performed with CHNSO-analyser (Model Euro EA 3000, Germany). TLC analysis were conducted on Sorbfil plates (Sorbpolimer, Russian Federation) using chloroform-ethylacetate, 40:1 (v/v). The substances were detected by a 10% solution of H₂SO₄ with subsequent heating at 100°C to 120°C for 2 to 3 minutes. Al₂O₃ (Reakhim, Russian Federation) was used for column chromatography. All the organic solvents were of analytical quality. Compounds 1 and 5 were obtained according to.⁷

Synthesis of Compound 2

A mixture of compound 1 (0.54 g, 1 mM) and hydroxylamine hydrochloride (0.54 g, 8 mM) in EtOH (15 mL) and NaOAc (0.65 g, 8 mM) was refluxed for 2 hours, poured into H₂O (100 mL), the precipitate was filtered, washed, and dried. The residue was crystallized from EtOH.

3-Oximino-17-(4-Methylpiperazin-1-yl)-Carbonylolup-20(29)-ene (2)

Yield: 0.42 g, 76%, as a white solid.

R _f 0.14.

MP: 192°С.

Anal. Calcd. for С₃₅Н₅₇N₃O₂ (Мr 551.839): С 75.72; Н 10.03; N 7.16. Found: С 76.18, Н 10.41, N 7.61.

¹H NMR (300 MHz, CDCl₃): δ 0.86 (3H, s, H-25), 0.92 (3H, s, H-26), 0.96 (3H, s, H-24), 1.02 (3H, s, H-27), 1.12 (3H, s, H-23), 1.22-2.12 (21Н, m, H-1, H-2, H5-H7, H-9, H11-H13, H-15, H-16, H-18, H-21, H-22), 1.67 (3Н, s, H-30), 2.06-2.18 (4Н, m, H-3′, H-5′), 2.29 (3Н, s, H-7′), 2.32-2.56 (3Н, m, H-13, H-16), 2.84-3.20 (7Н, m, H-19, H-3, H-2′, H-6′, ОН), 4.57 (1H, s, H-29), 4.73 (1H, s, H-29), 9.21 (1H, s, N-OH).

¹³C NMR (CDCl₃, 75.5 MHz): δ 14.5 (C-27), 15.8 (C-25), 15.9 (C-26), 19.3 (C-11), 19.6 (C-30), 20.9 (C-6), 21.6 (C-24), 22.9 (C-23), 25.6 (C-12), 26.5 (C-2), 29.7 (C-15), 31.3 (C-21), 32.4 (C-16), 33.6 (C-22), 34.1 (C-7), 35.9 (C-4), 36.9 (C-13), 38.1 (C-10), 39.6 (C-1), 40.8 (C-8), 41.8 (C-14), 45.5 (C-7′), 45.9 (C-19), 47.3 (C-17), 50.2 (С-18), 52.6 (C-2′, C-6′), 54.3 (C-5′), 54.5 (С-3′), 55.0 (C-9), 55.2 (С-5), 109.1 (C-29), 151.2 (C-20), 167.3 (C-3), 173.4 (C-28).

Synthesis of Compound 3

A solution of compound 2 (0.55 g, 1 mmol) in dioxane (30 mL) and 0.4 mL of SOCl₂ was stirred at room temperature for 30 minutes, then poured into H₂O (100 mL), the precipitate was filtered, washed, dried, and crystallized from EtOH.

3-Oxo-3а-Homo-3а-Aza-17-(4-Methylpiperazin-1-yl)-Carbonylo-Lup-20(29)-ene (3)

Yield 0.36 g, 87%, as a yellow solid.

R _f 0.10.

MP: 2270–229°С.

[α]_D ²⁰ +12.0° (c 1.00, CHCl₃);

Anal. Calcd. for С₃₅Н₅₇N₂O₂ (Мr 551.86): С 76.18; Н 10.41; N 7.61. Found: С 76.27; Н 10.52; N 7.71.

¹H NMR (300 MHz, CDCl₃): δ 0.89 (3H, s, H-25), 0.92 (3H, s, H-26), 1.01 (3H, s, H-24), 1.21 (3H, s, H-27), 1.29 (3H, s, H-23), 1.22-2.08 (21Н, m, H-1, H-2, H5-H7, H-9, H11-H13, H-15, H-16, H-18, H-21, H-22), 1.69 (3Н, s, H-30), 2.06-2.18 (4Н, m, H-3′, H-5′), 2.29 (3Н, s, H-7′), 2.43-2.55 (3Н, m, H-13, H-16), 2.68-3.20 (5Н, m, H-19, H-2′, H-6′), 4.59 (1H, s, H-29), 4.71 (1H, s, H-29), 6.13-6.22 (1H, m, NH);

¹³C NMR (CDCl₃, 75.5 MHz): δ 14.4 (C-27), 15.8 (C-25), 15.9 (C-26), 19.5 (C-11), 19.6 (C-30), 20.9 (C-6), 21.6 (C-24), 22.4 (C-23), 25.8 (C-12), 27.1 (C-2), 29.7 (C-15), 30.9 (C-21), 32.2 (C-16), 33.3 (C-22), 33.7 (C-7), 35.9 (C-4), 37.0 (C-13), 37.4 (C-10), 39.1 (C-1), 40.3 (C-8), 40.6 (C-14), 45.4 (C-7′), 45.9 (C-19), 47.3 (C-17), 51.1 (С-18), 52.3 (C-2′, C-6'), 53.7 (C-5'), 54.5 (С-3'), 55.0 (C-9), 56.9 (С-5), 109.7 (С-29), 150.4 (С-20), 173.8 (С-28), 176.7 (C-3).

Synthesis of Compound 4

LiAlH₄ (0.456 g; 12 mM) was added to a solution of compound 3 (0.55 g; 1 mM) in dry THF (30 mL) under a nitrogen atmosphere. The reaction was heated for 1 hour, then quenched with a solution of 1 M HCl and extracted with chloroform (3 × 60 mL). The combined organic layers were dried over CaCl₂, concentrated in vacuo and chromatographed on a Al₂O₃ column eluted with chloroform.

3-Deoxy-3а-Homo-3а-Aza-17-(4-Methylpiperazin-1-yl)-Carbonylolup-20(29)-ene (4)

Yield 0.46 g, 87%, as a white solid.

Rf 0.08.

MP: 153°С.

[α]_D ²⁰ +25° (c 1.00, CHCl₃).

Anal. Calcd. for С₃₅Н₅₉N₃O (Мr 537.88): C 78.16; Н 11.06; N 7.81. Found: С 78.24; Н 11.14; N 7.92.

¹H NMR (300 MHz, CDCl₃): δ 0.89 (3H, s, H-25), 0.92 (3H, s, H-26), 0.98 (3H, s, H-24), 1.02 (3H, s, H-27), 1.12 (3H, s, H-23), 1.17-2.08 (22Н, m, H-1, H-2, H5-H7, H-9, H11-H13, H-15, H-16, H-18, H-21, H-22), 1.69 (3Н, s, H-30), 2.29-2.45 (7Н, m, H-13, H-16, H-3′, H-5′), 2.32 (3Н, s, H-7′), 2.51-3.02 (6H, m, H-3, H-19, H-2′, H-6′), 3.03-3.21 (1H, m, NH), 4.54 (1H, s, H-29), 4.68 (1H, s, H-29).

¹³C NMR (CDCl₃, 75.5 MHz): δ 14.5 (C-27), 15.7 (C-25), 16.4 (C-26), 19.1 (C-11), 19.6 (C-30), 20.9 (C-6), 21.3 (C-24), 22.7 (C-23), 25.8 (C-12), 26.9 (C-2), 29.0 (C-15), 31.3 (C-21), 33.5 (C-16), 33.9 (C-22), 34.1 (C-7), 35.9 (C-3), 36.9 (C-13), 38.3 (C-10), 39.4 (C-1), 40.7 (C-8), 41.8 (C-14), 45.5 (C-7′), 45.9 (C-19), 47.3 (C-17), 50.2 (С-18), 52.4 (C-2′, C-6′), 54.3 (C-5′), 54.5 (С-3′), 55.0 (C-9), 56.9 (С-5), 63.2 (С-3), 109.8 (С-29), 150.2 (С-20), 174.1 (С-28).

Minimum Inhibitory Concentration

MIC in LB medium for BW25113 E. coli and BW25113 E. coli ΔtolC (JW5503 from Keio collection) was determined using broth microdilution assay.²² The cell concentration was adjusted to approximately 5 × 105 cells/mL. The tested compounds were serially diluted twice in a 96-well 2 mL microplate (200 µL per well). Microplates were covered and incubated at 37°C with shaking. The OD600 of each well was measured, and the lowest concentration of the tested compound that resulted in no growth after 16–20 hours was assigned to the MIC value.

Testing the In Vivo Activity of 4

The reporter strain dtolC-pDualrep2 was used as previously described.¹⁹ Briefly, 2 µL of compound 4 solutions 10 mg/mL were applied to an agar plate that already contained a lawn of the reporter strain. 10 mM erythromycin and 20 µM levofloxacin solutions were used as controls. After being incubated overnight at 37°C, the plate was scanned by ChemiDoc (Bio-Rad): “Cy3-blot” for RFP and “Cy5-blot” for Katushka2S.

Cytotoxicity Measurements

The measurements were carried out using the standard MTT method.²³ 3000 cells per well for PC3, Huh7, and 22Rv1 cell lines or 4000 cells per well for VA13 and LNCAP were plated out in 135 µL of media in 96-well plate. DMEM-F12 media (Gibco) was used for VA13 and Huh7, and RPMI (Gibco) was used for PC3, 22Rv1 and LNCAP cell lines. Media was supplemented with 10% heat-inactivated FBS, 1 × Penstrep, 1 × Glutamax (Gibco). Cells were incubated in the 5% CO₂ incubator for first 16 hours without treating. Then 15 µL of media-dimethyl sulfoxide (DMSO) solutions of tested substances to the cells (final DMSO concentrations in the media were 1% or less) and treated cells 72 hours (triplicate each). The MTT reagent then was added to cells up to the final concentration of 0.5 g/L (10× stock solution in phosphate buffered saline was used) and incubated for 2 hours at 37°C in the incubator, under an atmosphere of 5% CO₂. The MTT solution was then discarded and 140 µL of DMSO was added. The plates were swayed on a shaker (80 rpm) to solubilize the formazan. The absorbance was measured using a microplate reader (VICTOR X5 Plate Reader) at a wavelength of 565 nm (in order to measure the formazan concentration). The results were used to construct a dose-response graph and to estimate CC₅₀ value by Prism software (GraphPad Software, Inc.).

Footnotes

Acknowledgments

Compounds 1-5 were synthesized on theme No. АААА-А17-117011910023-2.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Biological screening of antibacterial activity was supported by grant from the Russian Foundation for Basic Research (project No. 18-34-20055). Cytotoxicity testing of compound 4, expert opinion, discussion and manuscript preparation was supported by grant from the Russian Science Foundation (project No. 17-74-30012, IBG RAS Ufa). Evaluation of cytotoxic activity of compound 5 was supported by grant from the Russian Science Foundation (project No. 17-74-10204).

References

Csuk

. Betulinic acid and its derivatives: a patent review (2008-2013). Expert Opin Ther Pat. 2014;24(8):913-923.doi:10.1517/13543776.2014.927441

Lange

Abhari

BA.

Hinrichs

TM.

Fulda

Liese

. Identification of a novel oxidative stress induced cell death by sorafenib and oleanolic acid in human hepatocellular carcinoma cells. Biochem Pharmacol. 2016;118:9-17.doi:10.1016/j.bcp.2016.08.011

Jesus

JA.

Lago

JHG.

Laurenti

MD.

Yamamoto

ES.

Passero

LFD

. Antimicrobial activity of oleanolic and ursolic acids: an update. J Evid Based Complementary Altern Med. 2015;2015(5):1-14.doi:10.1155/2015/620472

Zhou

Zhang

R-H.

Wang

G-B.

Liao

S-G

. Prodrugs of triterpenoids and their derivatives. Eur J Med Chem. 2017;131:222-236.doi:10.1016/j.ejmech.2017.03.005

Urban

Kvasnica

Dickinson

Sarek

. Biologically active triterpenoids usable as prodrugs. In: Bates

AR.

, ed. Terpenoids and Squalene: Biosynthesis; Function and Health Implications. New York: Nova Science Publishers; 2015:25-50.

Mierina

Vilskersts

Turks

. Delivery systems for birch-bark triterpenoids and their derivatives in anticancer research. Curr Med Chem. 2018;25:1-29.doi:10.2174/0929867325666180530095657

Kazakova

OB.

Giniyatullina

GV.

Tolstikov

GA.

Medvedeva

NI.

Utkina

TM.

Kartashova

. Synthesis, modification, and antimicrobial activity of the N-methylpiperazinyl amides of triterpenic acids. Russ J Bioorgan Chem. 2010;36(3):383-389.doi:10.1134/S1068162010030155

Giniyatyllina

GV.

Smirnova

IE.

Kazakova

et al . Synthesis and anticancer activity of aminopropoxytriterpenoids. Med Chem Res. 2015;24(9):3423-3436.doi:10.1007/s00044-015-1392-y

Wolfram

RK.

Fischer

Kluge

Ströhl

Al-Harrasi

Csuk

. Homopiperazine-rhodamine B adducts of triterpenoic acids are strong mitocans. Eur J Med Chem. 2018;155:869-879.doi:10.1016/j.ejmech.2018.06.051

10.

Robinson

GN.

Wild

CT.

Ashton

et al. 2006

Novel betulin derivatives; preparation thereof and use thereof.

Patent WO 2006/053255;

11.

Regueiro-Ren

Liu

Swidorski

et al.

C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors.

Patent US 8802661B2; 2014

12.

Gnoatto

SCB.

Susplugas

Dalla Vechia

Vechia

et al . Pharmacomodulation on the 3-acetylursolic acid skeleton: Design, synthesis, and biological evaluation of novel N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-O-acetylursolamide derivatives as antimalarial agents. Bioorg Med Chem. 2008;16(2):771-782.doi:10.1016/j.bmc.2007.10.031

13.

Nie

Luo

J-G.

Wang

X-B

et al . Synthesis of new α-glucosidase inhibitors based on oleanolic acid incorporating cinnamic amides. Chem Pharm Bull. 2011;59(8):1051-1056.doi:10.1248/cpb.59.1051

14.

Gnoatto

SCB.

Dalla Vechia

Lencina

et al . Synthesis and preliminary evaluation of new ursolic and oleanolic acids derivatives as antileishmanial agents. J Enzyme Inhib Med Chem. 2008;23(5):604-610.doi:10.1080/14756360802204870

15.

Silva

GNS.

Schuck

DC.

Cruz

et al . Investigation of antimalarial activity, cytotoxicity and action mechanism of piperazine derivatives of betulinic acid. Trop Med Int Health. 2015;20(1):29-39.doi:10.1111/tmi.12395

16.

Kazakova

OB.

Giniyatullina

GV.

Medvedeva

et al . Synthesis and cytotoxicity of triterpene seven-membered cyclic amines. Russ J Bioorgan Chem. 2014;40(2):198-205.doi:10.1134/S106816201402006X

17.

Medvedeva

NI.

Kazakova

OB.

Lopatina

et al . Synthesis and antimycobacterial activity of triterpenic A-ring azepanes. Eur J Med Chem. 2018;143:464-472.doi:10.1016/j.ejmech.2017.11.035

18.

Fralick

. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli . Journal of Bacteriology. 1996;178(19):5803-5805.doi:10.1128/jb.178.19.5803-5805.1996

19.

Osterman

IA.

Komarova

ES.

Shiryaev

et al . Sorting out antibiotics' mechanisms of action: a double fluorescent protein reporter for high throughput screening of ribosome and DNA biosynthesis inhibitors. Antimicrobial Agents Chemotherapy. 2016;12:7481-7489.doi:10.1128/AAC.02117-16

20.

Ivanenkov

YA.

Machulkin

AE.

Garanina

et al . Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA. Bioorg Med Chem Lett. 2019;29(10):1246-1255.doi:10.1016/j.bmcl.2019.01.040

21.

Petrov

RA.

Maklakova

SY.

Ivanenkov

et al . Synthesis and biological evaluation of novel mono- and bivalent ASGP-R-targeted drug-conjugates. Bioorg Med Chem Lett. 2018;28(3):382-387.doi:10.1016/j.bmcl.2017.12.032

22.

Wiegand

Hilpert

Hancock

REW

. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163-175.doi:10.1038/nprot.2007.521

23.

Mosmann

. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63.doi:10.1016/0022-1759(83)90303-4

Synthesis and Сytotoxicity of A-Azepanobetulinic Acid N -Methyl-Piperazinylamide

Abstract

Keywords

Experimental

General

Synthesis of Compound 2

3-Oximino-17-(4-Methylpiperazin-1-yl)-Carbonylolup-20(29)-ene (2)

Synthesis of Compound 3

3-Oxo-3а-Homo-3а-Aza-17-(4-Methylpiperazin-1-yl)-Carbonylo-Lup-20(29)-ene (3)

Synthesis of Compound 4

3-Deoxy-3а-Homo-3а-Aza-17-(4-Methylpiperazin-1-yl)-Carbonylolup-20(29)-ene (4)

Minimum Inhibitory Concentration

Testing the In Vivo Activity of 4

Cytotoxicity Measurements

Footnotes

Acknowledgments

Declaration of Conflicting Interests

Funding

References